Genetic and Molecular Markers in Head and Neck Cancer and Thyroid Cancer
Studies tumour and blood markers in adults with head and neck cancer.
Plain-language title generated from the registry record
Registry title: Head and Neck Cancer Strategies
Key facts
- Where
- Aarhus N, DenmarkSee the site
Where in Denmark
- Aarhus University HospitalAarhus N, DenmarkNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aarhus University Hospital
- Trial code
- NCT07909603
- Record updated
- 2 November 2026
- Original description
The overall aim is to investigate whether genetic and other molecular markers can improve the diagnosis, assessment of treatment response, and detection of recurrence in patients with head and neck cancer. In the longer term, the project aims to contribute to more individualised treatment strategies for our patients.Read full original descriptionShow less
Strategies for Individualized Management of Head and Neck Cancer
The overall aim is to investigate whether genetic and other molecular markers can improve the diagnosis, assessment of treatment response, and detection of recurrence in patients with head and neck cancer. In the longer term, the project aims to contribute to more individualised treatment strategies for our patients.
The project will involve comprehensive analyses of tumour tissue and blood, including extensive genetic sequencing and other molecular profiling. Importantly, the research analyses will not have any implications for the clinical management or treatment of the individual patient included in the study.
Inclusion: Tumor more than 1 cm in the head and neck and suspecion of cancer.
Exclusion: Tumor too small to assure tissue for correct diangosis.